Últimas noticias sobre Pharma Mar (OTC:PHMMF) Bolsa

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar SA

High-rolling investors have positioned themselves bullish on Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in COF often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Capital One Finl. This is not a typical pattern.
The sentiment among these major traders is split, with 54% bullish and 27% bearish. Among all the options we identified, there was one put, amounting to $39,480, and 10 calls, totaling $578,154.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $125.0 and $230.0 for Capital One Finl, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Capital One Finl's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Capital One Finl's whale activity within a strike price range from $125.0 to $230.0 in the last 30 days. 
<h3>Capital One Finl 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052857_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.4</td>
<td>$3.1</td>
<td>$3.4</td>
<td>$200.00</td>
<td>$170.0K</td>
<td>5.3K</td>
<td align="right">500</td>
</tr>
<tr>
<td>COF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$76.5</td>
<td>$74.3</td>
<td>$75.97</td>
<td>$125.00</td>
<td>$75.9K</td>
<td>40</td>
<td align="right">0</td>
</tr>
<tr>
<td>COF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$29.6</td>
<td>$29.0</td>
<td>$29.18</td>
<td>$185.00</td>
<td>$55.4K</td>
<td>250</td>
<td align="right">19</td>
</tr>
<tr>
<td>COF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/13/25</td>
<td>$1.45</td>
<td>$1.45</td>
<td>$1.45</td>
<td>$202.50</td>
<td>$46.1K</td>
<td>1.4K</td>
<td align="right">323</td>
</tr>
<tr>
<td>COF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.75</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$212.50</td>
<td>$45.0K</td>
<td>188</td>
<td align="right">750</td>
</tr>
</tbody>
</table>

<h3>About Capital One Finl</h3>
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Having examined the options trading patterns of Capital One Finl, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Capital One Finl</h3>
<ul>
<li>With a trading volume of 911,054, the price of COF is down by -0.81%, reaching $194.05.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 48 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Capital One Finl</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $233.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Capital One Finl, which currently sits at a price target of $233. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Capital One Finl, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

A Closer Look at Capital One Finl's Options Market Dynamics

Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-06-05. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Ciena will report an earnings per share (EPS) of $0.52.
Ciena bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS beat by $0.23, leading to a 3.83% increase in the share price on the subsequent day.
Here's a look at Ciena's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.65</td>
<td>0.26</td>
<td>0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.64</td>
<td>0.54</td>
<td>0.35</td>
<td>0.27</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>6.0%</td>
<td>-5.0%</td>
<td>-6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1749052857_0_0.png" alt="eps graph" />
<h3>Performance of Ciena Shares</h3>
Shares of Ciena were trading at $83.26 as of June 03. Over the last 52-week period, shares are up 74.96%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Opinions on Ciena</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Ciena.
Analysts have given Ciena a total of 14 ratings, with the consensus rating being Neutral. The average one-year price target is $79.93, indicating a potential 4.0% downside.
<h3>Understanding Analyst Ratings Among Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Juniper Networks, F5 and Lumentum Holdings, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Juniper Networks, with an average 1-year price target of $40.0, suggesting a potential 51.96% downside.</li>
<li>Analysts currently favor an Neutral trajectory for F5, with an average 1-year price target of $281.12, suggesting a potential 237.64% upside.</li>
<li>Analysts currently favor an Buy trajectory for Lumentum Holdings, with an average 1-year price target of $84.3, suggesting a potential 1.25% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Juniper Networks, F5 and Lumentum Holdings, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ciena</td>
<td>Neutral</td>
<td>3.33%</td>
<td>$471.82M</td>
<td>1.59%</td>
</tr>
<tr>
<td>Juniper Networks</td>
<td>Neutral</td>
<td>11.43%</td>
<td>$754.70M</td>
<td>1.33%</td>
</tr>
<tr>
<td>F5</td>
<td>Neutral</td>
<td>7.30%</td>
<td>$590.16M</td>
<td>4.44%</td>
</tr>
<tr>
<td>Lumentum Holdings</td>
<td>Buy</td>
<td>16.02%</td>
<td>$122.50M</td>
<td>-5.03%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Ciena ranks in the middle among its peers for revenue growth, with a growth rate of 3.33%. It is at the bottom for gross profit at $471.82M. Ciena is also at the bottom for return on equity at 1.59%.
<h3>All You Need to Know About Ciena</h3>
Ciena Corp is a network and technology company. It provides network hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks. It serves various industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises world-wide. The business activities function through Networking Platforms which generates maximum revenue; Platform Software and Services; Blue Planet Automation Software, and Global Services segments. Geographically, the company derives a majority of its revenue from the Americas, and the rest from the Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA) region.
<h3>Key Indicators: Ciena's Financial Health</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Ciena's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.33% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.16%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Ciena's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.59%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Ciena's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.79%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Ciena's debt-to-equity ratio is below the industry average at 0.57, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/CIEN/earnings">To track all earnings releases for Ciena visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

CIEN

Insights Ahead: Ciena's Quarterly Earnings

Elon Musk's brain-computer interface company Neuralink has raised $600 million in new funding at a $9 billion valuation, according to <a href="https://www.semafor.com/article/05/27/2025/elon-musks-neuralink-raises-fresh-cash-at-9b-valuation">Semafor</a>. The fundraising round follows the company's first human implant earlier this year and expands its efforts to develop medical applications for its brain chip technology.
Musk has previously stated that humans may be able to surf the web with their thoughts by the end of 2030, Reuters reported. The claim has drawn renewed attention amid the funding news. In January, <a href="https://www.technologyreview.com/2025/01/16/1110017/what-to-expect-from-neuralink-in-2025/">MIT Technology Review</a> noted that neuroscience experts have questioned the feasibility of this timeline.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
<h2 class="wp-block-heading">Clinical Trials Underway</h2>
<a href="https://www.benzinga.com/news/24/05/39053422/elon-musks-neuralink-initiates-brain-implant-study-aims-to-enroll-3-patients-for-revolutionary-digit">Neuralink began human trials</a> in 2024 after receiving U.S. Food and Drug Administration approval to implant its brain-computer interface, or BCI, in paralysis patients. The first participant, Noland Arbaugh, underwent surgery in January 2024 and was later shown controlling a computer cursor and playing online chess using only his thoughts, according to Reuters.
In May 2024, Neuralink registered a clinical study in the U.S. government trials database, aiming to enroll three participants. The company is also expanding its trial footprint internationally, having received <a href="https://www.benzinga.com/24/11/42103314/elon-musks-neuralink-gets-green-light-to-launch-brain-chip-trial-in-canada-recruitment-is-now-open">approval from Health Canada</a> in November 2024 to recruit six patients for a study testing the device's safety and efficacy in enabling cursor movement through brain activity.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;&nbsp;
While early demonstrations suggest meaningful progress, the technology remains highly experimental. Neuralink is currently conducting an <a href="https://www.themiamiproject.org/neuralink/">early feasibility study</a> called the Precise Robotically Implanted Brain-Computer Interface, with three participants implanted. The company has not yet registered a pivotal trial — the FDA-required phase for commercial approval — and continues to modify its device design, including electrode and surgical robot upgrades, according to MIT Technology Review.
<h2 class="wp-block-heading">Valuation Surges Amid Musk's AI Risk Narrative</h2>
Neuralink's valuation has risen sharply to $9 billion, up from an estimated $5 billion in mid-2023, according to Semafor. The publication reported that the recent funding round drew support from existing investors aligned with Elon Musk's other companies, including Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX.
Musk has repeatedly positioned Neuralink as a safeguard against artificial intelligence threats. In a May 2 <a href="https://x.com/elonmusk/status/1918188145549468135">post on X</a>, he stated that Neuralink's brain chips must become widely available to ensure humans remain competitive as AI advances. He previously told <a href="https://edition.cnn.com/2023/04/17/tech/elon-musk-ai-warning-tucker-carlson">CNN</a> in 2023 that brain-computer interfaces could help reduce civilizational risk posed by artificial general intelligence.
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">Industry Context And Competitors</h2>
The global BCI market is projected to reach $6.52 billion by 2030, growing at a compound annual growth rate of 18.15% from 2025 to 2030, according to <a href="https://www.grandviewresearch.com/industry-analysis/brain-computer-interfaces-market">Grand View Research</a>.&nbsp;
Competitors are also gaining traction. <a href="https://www.reuters.com/technology/musks-neuralink-faces-federal-probe-employee-backlash-over-animal-tests-2022-12-05/">Synchron</a> was the first to receive FDA approval to implant a BCI in U.S. patients, and Precision Neuroscience recently <a href="https://www.globenewswire.com/news-release/2025/04/17/3063418/0/en/Precision-Neuroscience-Receives-FDA-Clearance-for-High-Resolution-Cortical-Electrode-Array.html">announced</a> regulatory clearance for its minimally invasive device.&nbsp;
As Neuralink expands its human trials, it faces pressure to keep pace with rivals and regulatory scrutiny. According to Reuters, FDA found quality control issues in the company's animal research lab, and U.S. Department of Agriculture's Inspector General have raised concerns over the pace and integrity of its experiments.
<h2 class="wp-block-heading">Looking Ahead</h2>
With significant competition, regulatory hurdles, and ethical concerns in play, Neuralink's ability to deliver on Musk's ambitious timeline will remain under close watch by investors, scientists, and the public alike.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

News

TSLA

'Web-Surfing With Your Brain' by 2030? Neuralink's $9B Valuation Sparks Debate Over Musk's Telepathy Timeline

Investors with a lot of money to spend have taken a bearish stance on Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with U, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 16 options trades for Unity Software.
This isn't normal.
The overall sentiment of these big-money traders is split between 43% bullish and 56%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $174,636, and 15, calls, for a total amount of $558,876.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $42.0 for Unity Software during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Unity Software options trades today is 5883.5 with a total volume of 16,746.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Unity Software's big money trades within a strike price range of $20.0 to $42.0 over the last 30 days.
<h3>Unity Software 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052852_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>U</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$5.9</td>
<td>$4.9</td>
<td>$5.67</td>
<td>$25.00</td>
<td>$174.6K</td>
<td>30</td>
<td>308</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.33</td>
<td>$1.2</td>
<td>$1.29</td>
<td>$42.00</td>
<td>$51.6K</td>
<td>1.4K</td>
<td>400</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.03</td>
<td>$1.01</td>
<td>$1.03</td>
<td>$30.00</td>
<td>$51.1K</td>
<td>38.6K</td>
<td>2.9K</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$0.6</td>
<td>$0.52</td>
<td>$0.58</td>
<td>$28.00</td>
<td>$46.8K</td>
<td>1.5K</td>
<td>2.1K</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$1.53</td>
<td>$1.52</td>
<td>$1.52</td>
<td>$36.00</td>
<td>$45.9K</td>
<td>606</td>
<td>359</td>
</tr>
</tbody>
</table>

<h3>About Unity Software</h3>
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
Following our analysis of the options activities associated with Unity Software, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Unity Software</h3>
<ul>
<li>Currently trading with a volume of 6,277,297, the U's price is up by 5.71%, now at $27.7. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 64 days.</li>
</ul>
<h3>What Analysts Are Saying About Unity Software</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $28.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Unity Software with a target price of $30. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Unity Software with a target price of $28. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Unity Software, maintaining a target price of $25. 
&#x2A; In a positive move, an analyst from Jefferies has upgraded their rating to Buy and adjusted the price target to $29. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Unity Software, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on Unity Software Options

In the current session, the stock is trading at $136.76, after a 0.09% spike. Over the past month, Live Nation Entertainment Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) stock increased by 4.23%, and in the past year, by 51.54%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1749052838_0.png" alt="Past Year Chart" />

<h3>Evaluating Live Nation Entertainment P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 365.98 in the Entertainment industry, Live Nation Entertainment Inc. has a lower P/E ratio of 46.32. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749052838_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Live Nation Entertainment

ADMA Biologics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NYSE">ADMA</a>) short percent of float has risen 8.03% since its last report. The company recently reported that it has 13.33 million shares sold short, which is 6.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.08 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>ADMA Biologics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052834_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ADMA Biologics has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing ADMA Biologics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, ADMA Biologics's peer group average for short interest as a percentage of float is 12.93%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

ADMA

How Is The Market Feeling About ADMA Biologics?

Dollar General Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) shares traded under pressure on Wednesday morning, despite reporting on Tuesday that it had achieved <a href="https://www.benzinga.com/markets/earnings/25/06/45768682/dollar-tree-q1-same-store-sales-jump-5-4-warns-of-near-term-profit-drop-on-tariff-pressure-transition-costs">healthy same-store sales growth</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<h1 class="wp-block-heading">BofA Securities On Dollar General</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ad8d48b85e930001f97170/robert-ohmes">Analyst Robert Ohmes</a> maintained a Buy rating, while raising the price target from $115 to $135.
Dollar General reported fiscal first-quarter earnings of $1.78 per share, significantly beating Street expectations of $1.47 per share, Ohmes said in a note. Same-store sales grew 2.4%, much higher than the consensus of 1.1%, driven by 2.7% ticket growth, while traffic declined by 0.3%, he added.
Management raised the low end of their full-year earnings guidance by 10 cents per share to $5.20-$5.80 per share, "reflecting 1Q upside as well as tariff impact uncertainty," the analyst stated. Dollar General's Back to Basics initiatives seem to be working, "which should continue driving efficiencies over time," he further wrote.
<h1 class="wp-block-heading">Truist Securities On Dollar General</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59493ca670ed7a0001097213/scot-ciccarelli">Analyst Scot Ciccarelli</a> reiterated a Hold rating, while lifting the price target from $93 to $112.
Dollar General's quarterly results were better than was initially expected, Ciccarelli said. The company delivered positive comps in all three months of the quarter and across all four of its merchandise categories, he added.
"While we think it's fair to question the sustainability of these trends (tariffs, consumer trends, product mix, etc.), the year is off to a solid start," the analyst wrote. The company raised its full-year comps guidance by 30 basis points (bps) to 1.5%-2.5% and its earnings outlook to $5.20-$5.80 per share, from $5.10-$5.80 per share, the analyst stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">JPMorgan On Dollar General</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reaffirmed a Neutral rating, while raising the price target from $88 to $95.
Dollar General reported its earnings around 19% higher than Street expectations, with the outperformance being driven by same-store-sales growth of 2.4% versus a consensus of 1.3%, gross margin expanding by 78 bps to 31.0% and SG&amp;A deleverage of 77bps to 25.4%, Boss said.
Management has raised the low end of its 2025 revenue growth outlook to 3.7%-4.7%, up from its prior projection of 3.4%-4.4%, the analyst stated. The company indicated it could mitigate most of the potential tariff headwind by "negotiating cost concessions, shifting manufacturing to other countries where possible, re-engineering products, or finding substitute products," he further wrote.
<h1 class="wp-block-heading">Telsey Advisory Group On Dollar General</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e301e08430dee0001c88c8d/joseph-feldman">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e301e08430dee0001c88c8d/joseph-feldman">Joseph Feldman</a> maintained a Market Perform rating, while taking the price target higher from $100 to $120.
Dollar General posted operating margins of 5.5%, beating the consensus of 4.7%, Feldman said. Although the company's core lower-income consumers are facing spending constraints, the middle- and higher-income households are shopping more frequently and spending more, he added.
While traffic declined by 0.3%, "it was up 4% on a two-year stacked basis, and it has been positive in 2Q25-to-date," the analyst wrote. Dollar General's Back-to-Basics initiatives resulted in market share gains in both consumables and non-consumables, he further stated.
<h1 class="wp-block-heading">KeyBanc Capital Markets On Dollar General</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59009b5a0bd9910001e5f2aa/bradley-thomas">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59009b5a0bd9910001e5f2aa/bradley-thomas">Bradley Thomas</a> reiterated a Sector Weight rating on the stock.
Dollar General reported better-than-expected results, with its strategic initiatives taking hold, Thomas said. The company achieved positive comps in consumables, apparel, home and seasonal, with the latter two categories being up 3% in the quarter, he added.
"The gross margin outlook is favorable, supported by 60 bps lower shrink, which could continue this year and still leave 20 bps incremental improvement opportunity after 2025," he further wrote.
DG Price Action: Shares of Dollar General had declined by 1.76% to $110.61 at the time of publication on Wednesday.
Read More: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> </a> • <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">Dollar General Boosts Annual Outlook Despite Ongoing Tariff Uncertainty</a>
Photo: Shutterstock

Analyst Color

Earnings Beats

Guidance

Price Target

Reiteration

Analyst Ratings

Movers

Dollar General Posts Convincing Q1 Earning Beat, 'The Year Is Off To A Solid Start,' Could Mitigate Most Potential Tariff Headwinds

NNN REIT's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) short percent of float has risen 4.83% since its last report. The company recently reported that it has 5.39 million shares sold short, which is 3.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>NNN REIT Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NNN REIT has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NNN REIT's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, NNN REIT's peer group average for short interest as a percentage of float is 5.87%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is NNN REIT Gaining or Losing Market Support?

TOPS

TOP Ships Shares Halted On Circuit Breaker To The Upside, Stock Now Up 74.1%

Sysco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>) short percent of float has risen 5.75% since its last report. The company recently reported that it has 15.95 million shares sold short, which is 3.68% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Sysco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052824_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sysco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Sysco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Sysco's peer group average for short interest as a percentage of float is 5.43%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Sysco?

SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) has outperformed the market over the past 20 years by 7.93% on an annualized basis producing an average annual return of 16.26%. Currently, SBA Communications has a market capitalization of $24.66 billion. 
Buying $1000 In SBAC: If an investor had bought $1000 of SBAC stock 20 years ago, it would be worth $21,046.26 today based on a price of $229.48 for SBAC at the time of writing.
<h3>SBA Communications's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749052822_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SBAC

Here's How Much $1000 Invested In SBA Communications 20 Years Ago Would Be Worth Today

Barclays analyst Jiong Shao maintains NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) with a Underweight and lowers the price target from $4 to $3.

Barclays Maintains Underweight on NIO, Lowers Price Target to $3

Jefferies analyst Sheila Kahyaoglu maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and raises the price target from $230 to $250.

Jefferies Maintains Buy on Boeing, Raises Price Target to $250

Jefferies analyst Joseph Gallo maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $410 to $520.

CRWD

Jefferies Maintains Buy on CrowdStrike Holdings, Raises Price Target to $520

Jefferies analyst Brent Thill maintains Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) with a Hold and raises the price target from $15 to $17.

ASAN

Jefferies Maintains Hold on Asana, Raises Price Target to $17

<a href="https://www.bloomberg.com/news/articles/2025-06-04/jpmorgan-plans-to-offer-clients-financing-against-crypto-etfs?srnd=homepage-americas">https://www.bloomberg.com/news/articles/2025-06-04/jpmorgan-plans-to-offer-clients-financing-against-crypto-etfs?srnd=homepage-americas</a>

General

'JPMorgan Plans to Offer Clients Financing Against Crypto ETFs'- Bloomberg

CIBC analyst Mark Jarvi maintains Algonquin Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) with a Neutral and raises the price target from $5.75 to $6.25.

CIBC Maintains Neutral on Algonquin Power, Raises Price Target to $6.25

<a href="https://www.ft.com/content/0c76f3c2-7213-42a5-8f30-b101b7616db0">https://www.ft.com/content/0c76f3c2-7213-42a5-8f30-b101b7616db0</a>

AAPL

BABA

'Apple and Alibaba's AI rollout in China delayed by Donald Trump's trade war'- Financial Times

Morgan Stanley analyst Betsy Graseck maintains Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) with a Overweight and raises the price target from $77 to $87.

Comments

Pharma Mar

Noticias

Últimas noticias sobre Pharma Mar (OTC:PHMMF) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL